CAXG China Aoxing Pharmaceutical Co., Inc. featured news, full reports, and detailed charts
China Aoxing Pharmaceutical Co., Inc. (CAXG/CAXG.OB) Wrap Up:
China Aoxing Pharmaceutical Co., Inc. engages in the research, development, manufacture, and marketing of various narcotics and pain management pharmaceutical products in generic and formulations in China. Its products include Naloxone, an opioid antagonist for pain, shock, alcoholism, and cerebral infarction; Oxycodone, a derivative of the semi-synthetic opioid, alkaloid thebaine for acute pain; Tilidine, a opioid analgesic drug used in the treatment of moderate to severe pain associated with cancer, post surgery, and other forms of pain; and Buprenorphine, an opioid used as an analgesic. The company also offers products, such as Compound Pholcodine Syrup and Codeine Phosphate for cough and...360 Employees
Founded in 2002
China Aoxing Pharmaceutical Co., Inc. (CAXG:OTC Bulletin Board Market)
LAST $1.25 USD
CHANGE TODAY +0.02 1.63%
VOLUME 8.6K
As of 3:33 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of China Aoxing Pharmaceutical Co., Inc. (CAXG)
|
OPEN
$1.23
|
PREVIOUS CLOSE
$1.23
|
|
|
DAY HIGH
$1.25
|
DAY LOW
$1.23
|
|
|
52 WEEK HIGH
08/13/09 - $1.95
|
52 WEEK LOW
04/3/09 - $0.20
|
|
|
MARKET CAP
114.6M
|
AVERAGE VOLUME 3 mo
20.0K
|
|
|
DILUTED EPS TTM
$-0.24
|
SHARES OUTSTANDING
91.7M
|
|
|
CAXG Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CAXG Top Compensated Officers
Ms. Hongyue Hao
Acting Chief Financial Officer
Age: 38
Total Annual Compensation: $29.3K
Executives, Board Directors
Compensation as of Fiscal Year 2009.
Key developments for China Aoxing Pharmaceutical Co., Inc. (CAXG)
China Aoxing Pharmaceutical Co., Inc. announced delayed 10-Q filing
11/16/2009
On 11/16/2009, China Aoxing Pharmaceutical Co., Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
China Aoxing Pharmaceutical Co., Inc. - Conference Presentation Call
11/10/2009
To update the company business including product portfolio, development pipeline, financial highlights and its long-term growth strategies
China Aoxing Pharmaceutical Co., Inc. - Conference Presentation Call
10/19/2009
China Aoxing Pharmaceutical Co., Inc. - Conference Presentation Calls
CAXG Competitors
| Company | Last | Change | |
| No competitor information is available for CAXG. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CAXG | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 11.6x |
|
| Price/Book | 4.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 10.5x |
|
|
CAXG |
||
|
CAXG transactions
| Type Date |
Target |
|
Private Placement
July 31, 2009 |
-- |
More Recent News About China Aoxing Pharmaceutical Co., Inc.
Would you like to leave a comment about China Aoxing Pharmaceutical Co., Inc. CAXG/CAXG.OB
Find out what social network information about China Aoxing Pharmaceutical Co., Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides China Aoxing Pharmaceutical Co., Inc. there is more great information available at Realpennies.com
